Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|September 25, 2025
New VSED Advance Directive: Improved Documentation to Avoid Late-Stage DementiaThaddeus Mason Pope, Lisa E Brodoff, Erin Mae Glass, et al.
Arzneimittel-Forschung|February 1, 1996
[Determination of systolic left ventricular time interval using the doppler technique. Analysis of aortic flow spectrum with transthoracic echocardiography]T Menzel, S Mohr-Kahaly, S Epperlein, et al.
Journal of Pain and Symptom Management|June 23, 2023
Clinical Guidelines for Voluntarily Stopping Eating and Drinking (VSED)Hope Wechkin, Robert Macauley, Paul T Menzel, et al.
Chest|October 18, 2000
Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension: changes after pulmonary thromboendarterectomyT Menzel, S Wagner, T Kramm, et al.
Molecular Biotherapy|June 1, 1992
Biologic and therapeutic efficacy of mafosfamide in patients with metastatic renal cell carcinomaA Schomburg, T Menzel, M Hadam, et al.
Zeitschrift Fur Kardiologie|January 22, 2000
[Determination of left ventricular mass by transthoracic three-dimensional echocardiography in patients with dilated cardiomyopathy]S Geil, L Rao, T Menzel, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 20, 2002
Butyrate and aspirin in combination have an enhanced effect on apoptosis in human colorectal cancer cellsT Menzel, J Schauber, F Kreth, et al.
Zeitschrift Fur Kardiologie|February 28, 1998
[Early results of pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension]E Mayer, T Kramm, M Dahm, et al.
Natural Immunity|May 1, 1992
In vivo and ex vivo antitumor activity in patients receiving low-dose subcutaneous recombinant interleukin-2A Schomburg, T Menzel, A Körfer, et al.
Molecular Biotherapy|June 1, 1991
Diminished expression of interleukin-2 receptors in vivo after prior chemotherapy in advanced cancer patients receiving recombinant interleukin-2J Atzpodien, A Körfer, M Hadam, et al.
Pageof 11